In this issue:
Infliximab healing improves long-term UC outcomes
Topical 5-ASAs prevent UC relapse
Relapse after infliximab withdrawal in CD
Corticosteroids/immuno-suppressants affect Quantiferon tests
Risks vs. benefits of infliximab/azathioprine for CD
Please login below to download this issue (PDF)